Rationale for Combination Therapy of Chronic Myelogenous Leukaemia With Imatinib and Irradiation or Alkylating Agents: Implications for Pretransplant Conditioning
British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6600242
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2002
Authors
Publisher
Springer Science and Business Media LLC